New to Meducation?
Sign up
Already signed up? Log In

Category

9
1
16

VPC1 2009 | Case 6

<p>ResearchToPractice.com/VPC109 - Case 6: A 63-year-old woman with T3N2M1, K-ras wild-type colon cancer underwent right colectomy and received CAPOX/bevacizumab for 10 months before discontinuin <br />therapy and one year later underwent a pancreaticoduodenectomy for a tumor involving the duodenum, jejunum and pancreas. Interviews conducted by Neil Love, MD. Produced by Research To Practice.</p>  
Dr Neil Love
over 11 years ago
5
1
15

VPC1 2009 | Case 2

ResearchToPractice.com/VPC109 - Case 2: A 77-year-old woman with a 9-cm, K-ras wild-type colon cancer and 42 out of 47 positive nodes who underwent resection of her primary tumor followed by adjuvant FOLFOX and subsequently developed a retroperitoneal metastasis treated with CAPOX/bevacizumab. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 11 years ago
9
1
15

VPB2 2009 | Case 3

ResearchToPractice.com/VPB209 - Case 3: A 72-year-old woman with cancer recurrence nine years after diagnosis of a 1-cm, poorly differentiated, node-positive, ER-positive, PR-negative, HER2-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 11 years ago
3
1
10

PCU2 2007 | Case 4 with Judd W Moul, MD

www.ProstateCancerUpdate.com – Conversations with Oncology Investigators. 60-year-old with de novo metastatic cancer. Produced by Research To Practice.  
Dr Neil Love
over 11 years ago
12
1
17

MTPL1 2007 | Case 12 presented by William N Harwin

MeetTheProfessors.com – 76yo, non-smoker, w/num. bilat. sub-cm nodules, right hilar mass, right lower lobe interstitial mrkngs; poorly diff. NSCLC in biopsy; rcvd 6 cyc. of carbo/paclitxl w/response; progressed, treated w/gefitinib; tumor response >40mo  
Dr Neil Love
over 11 years ago
4
1
57

MTPL1 2007 | Case 04 presented by Sara M Garrido

MeetTheProfessors.com – 70-year-old w/a 3-cm lesion in right upper lobe & 4.5-cm hilar mass w/metastasis to an inguinal lymph node; rcvd 6 cycles paclitaxel/carboplatin & bev w/good tumor response; currently receiving maintenance bev w/no adverse effects  
Dr Neil Love
over 11 years ago
0
1
57

MTPC1 2007 | Case 13 presented by Philip Glynn, MD

MeetTheProfessors.com – 48yo w/res. of 3-cm, moderately well-diff. tumor into subserosa, 4/7+ nodes, 2 palp. liver lesions; biopsy revealed met disease; rcvd chemo/wedge resection of liver w/cryotherapy; rcvd 6mo 5-FU/leu, doing well 12 years later  
Dr Neil Love
over 11 years ago
10
1
34

MTPC1 2007 | Case 09 presented by Kapisthalam S Kumar, MD

MeetTheProfessors.com – 66yo w/resection of a 4-cm, moderately differentiated tumor in descending colon w/involvement of subserosa, 20 negative nodes; no lymphovascular invasion was seen, but pathologist noted multiple microabscesses adjacent to tumor  
Dr Neil Love
over 11 years ago
9
1
35

MTPC1 2007 | Case 08 presented by Daniel J Moriarty, MD

MeetTheProfessors.com – 62yo w/squamous cell carc. 3-4cm above anal verge; rcvd neoadj rad. therapy & 5-FU/mitomycin; tumor was not visible/palpable after chemo but seen on ultrasound; AP resection revealed submucosal disease, with 5/19 positive nodes  
Dr Neil Love
over 11 years ago
8
1
22

MTPC1 2007 | Case 07 presented by William G Reeves, MD

MeetTheProfessors.com – 84yo 3-cm tumor w/penetration of muscularis, 1/15 positive nodes, underwent right hemicolectomy; caretaker of wife who suffered a stroke; rcvd 6mo adj cape, contd care for wife, doing well 12mo later  
Dr Neil Love
over 11 years ago
6
1
73

MTPC1 2007 | Case 05 presented by Sara M Garrido, MD

MeetTheProfessors.com – 70yo, right hemicolectomy for 3-cm, well- to moderately difftd tumor, 3/15 pos. nodes; history of diabetes, laryngeal cancer treated with cis-based chemo & rad therapy, residual neuropathy; treated w/adj. cape for colon cancer  
Dr Neil Love
over 11 years ago
4
1
17

MTPC1 2007 | Case 03 presented by Michael A Schwartz, MD

MeetTheProfessors.com – 63yo w/prim. sigmoid, synch. liver mets, extensive pelvic disease; diverting colostomy; rcvd FOLFOX w/bev; CEA level dropped by 80% after 3 cycles; no tumor on sigmoidoscopy/laparotomy after 6 cycles; colostomy closed, began cape  
Dr Neil Love
over 11 years ago
3
1
11

MTPB3 2007 | Case 09 presented by Andrea F Stebel, MD

www.MeetTheProfessors.com – Case from the practice of Andrea F Stebel, MD; 66yo diagnosed with a 5-cm, ER-pos, PR-neg, HER2-neg sentinel lymph node-neg infiltrating lobular cancer, treated with lumpectomy/rad therapy presented to Drs Schwartzberg, Seidman  
Dr Neil Love
over 11 years ago
7
1
6

BCUS2 2007 | Tumor Panel Case Discussion 05

www.BreastCancerUpdate.com/Surgeons – An Audio Review Journal for Surgeons. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 11 years ago
10
1
12

BCU 3 | 06 - Tumor Panel

Miami Breast Cancer Conference Tumor Panel Discussion on Adjuvant Systemic Therapy  
Dr Neil Love
over 11 years ago
2
1
7

BCU 5 | 06 - MBCC Tumor Panel

Miami Breast Cancer Conference Tumor Panel: Monoclonal Antibodies in the Management of Early and Advanced Breast Cancer  
Dr Neil Love
over 11 years ago
11
1
10

BCU 6 | 06 - MBCC Tumor Panel

Miami Breast Cancer Conference Tumor Panel Discussion on Systemic Therapy of Metastatic Disease  
Dr Neil Love
over 11 years ago
1
1
28

SABCS Spin-Off | 06 - Tripathy

Outside a protocol setting, the combination of lapatinib and capecitabine provides the best potential risk/benefit profile for women with ER-negative, PR-negative, HER2-positive, node-positive disease with cancer recurrence after AC->TH.  
Dr Neil Love
over 11 years ago
1
1
12

BCU 3 | 07 - Tumor Panel

Tumor Panel Case Discussion: Brian Leyland-Jones, MD, PhD and Mark D Pegram, MD  
Dr Neil Love
over 11 years ago
0
1
12

BCU5 2007 | Interview with Tumor Panel Case Discussion 03

www.BreastCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 11 years ago